Key result
Between 2017 and 2021, prescriptions for ACE inhibitors decreased from 38% to 21%, while calcium channel blockers increased from 31% to 40%, becoming the most prescribed antihypertensive class.
Why the study?
The study was conducted to evaluate the prescribing trends and patterns of antihypertensives among hypertensive patients in primary care settings in Qatar.
Observational (n=2,185)
Yes
In primary care settings in Qatar, CCBs have replaced ACEIs as the most prescribed antihypertensive class between 2017 and 2021, aligning with current guidelines.
Answers are grounded in this paper and cite their sources.
Prescribing shifted toward CCBs and away from ACEIs/thiazides in Qatar primary care; supports guideline alignment but leaves open drivers and clinical outcomes.
Background: An observational retrospective study was conducted in the primary care setting in Qatar to evaluate the prescribing trends and patterns of antihypertensives in hypertensive patients. Methods: Included patients were adult patients (aged ≥18 years) diagnosed with essential hypertension and attending Primary Health Care Corporation (PHCC) clinics in Qatar between January 2017 and March 2021. A sample of 2185 patients was randomly selected. The data were collected from PHCC's electronic medical records system, Cerner©. Results: Angiotensin Converting Enzyme inhibitors (ACEIs) prescriptions decreased from 38% in 2017 to 21% in 2021, and that of Angiotensin Receptor Blockers (ARBs) from 37% in 2017 to 31% in 2021. Patients with prescribed Calcium Channel Blockers (CCBs) increased from 31% in 2017 to 40% in 2021. The prescribing of thiazide diuretics declined from 32% in 2017 to 9% in 2021. In 2017, the most prescribed antihypertensive class was ACEIs (38%), while the least prescribed antihypertensive class was loop diuretics (1.4%). In 2018, the most prescribed class of antihypertensives was CCBs (36%) and the least prescribed was vasodilators (0.1%). In 2019, 2020 and 2021, CCBs were the most prescribed. Conclusion: These findings are consistent with national and international guidelines for hypertension management and with published literature. Yet, there is still room for improvement to optimise antihypertensive prescribing practices. Prescribers need to address potential gaps and explore ways to enhance their hypertension management, so that patients have access to effective and evidence-based treatments.
No takes yet. Share an insight, caveat, or question.
Abdelkader et al. (2025) conducted an observational in Essential hypertension (n=2,185). Antihypertensive agents was evaluated on Prescribing trends and patterns of antihypertensives. Between 2017 and 2021, prescriptions for ACE inhibitors decreased from 38% to 21%, while calcium channel blockers increased from 31% to 40%, becoming the most prescribed antihypertensive class.
Synapse has enriched 10 related papers. Consider them for comparative context: